Veterinary Medicines

AURIZON EAR DROPS, SUSPENSION

Authorised
  • Marbofloxacin
  • Dexamethasone acetate
  • Clotrimazole
Download as PDF

Product identification

Medicine name:
AURIZON EAR DROPS, SUSPENSION
AURIZON, ausų lašai, suspensija
Active substance:
  • Marbofloxacin
  • Dexamethasone acetate
  • Clotrimazole
Target species:
  • Dog
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • Marbofloxacin
    3.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dexamethasone acetate
    1.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Clotrimazole
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Ear drops, suspension
Withdrawal period by route of administration:
  • Auricular use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS02CA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • Box containing 1 x 20 ml bottle
  • Box containing 1 x 30 ml bottle
  • Box containing 1 x 10 ml bottle

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/05/1674/001-003
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0124/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Aurizon 2023-11-30.pdf

Lithuanian (PDF)
Published on: 29/02/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."